Diagnosed with Cancer? Your two greatest challenges are understanding cancer and understanding possible side effects from chemo and radiation. Knowledge is Power!
Learn about conventional, complementary, and integrative therapies.
Dealing with treatment side effects? Learn about evidence-based therapies to alleviate your symptoms.
Click the orange button to the right to learn more.
- You are here:
- Home »
- Blog »
- Pancreatic Cancer »
- Repurposed Drugs for Pancreatic Cancer
Repurposed Drugs for Pancreatic Cancer
Repurposed Drugs for Pancreatic Cancer: What the Research Shows Repurposed drugs like metformin, ivermectin, and mebendazole show promise in pancreatic cancer research. Learn what the science says and how these therapies may help.
This article reviews what research currently says about repurposed drugs for pancreatic cancer.
Before I get to the topic of repurposed drugs, I would like to stress the idea of preparing your body for whatever cancer treatment you choose with:
I am a long-term survivor of an incurable blood cancer called multiple myeloma. My research and experience with evidence-based non-conventional therapies is the reason why I have lived in complete remission from my incurable blood cancer since achieving complete remission in early 1999. I have learned that the best way to manage aggressive cancers is to combine the best of conventional and evidence-based non-conventional therapies.
I have come to believe that therapy-induced side effects can be life-threatening while ruining quality of life. Consider therapies shown to reduce possible side effects.
Scroll down the page and post a question or a comment if there’s anything you’d like to know about breast cancer.
Good luck,
David Emerson
To Learn More About Repurposed Drugs for Cancer-
- Fenbendazole and Cancer: What the Research Really Shows”
- Mebendazole and Cancer: Anti-Tumor Mechanisms and Studies”
- Repurposed Drugs in Cancer Therapy: What the Science Shows”
- Metformin and Cancer: Why a Diabetes Drug Is Being Studied for Tumors
- Repurposed Drugs in Cancer Therapy: What the Science Shows
- Repurposed Drugs + Chemotherapy: Integrative Treatment
Repurposed drugs for cancers
What Are Repurposed Drugs for Pancreatic Cancer?
Repurposed drugs are medications originally developed for other conditions (e.g., diabetes or infections) that show anti-cancer effects. In pancreatic cancer, drugs like metformin, ivermectin, and mebendazole are being studied for their ability to:
- Slow tumor growth
- Trigger cancer cell death (apoptosis)
- Enhance chemotherapy effectiveness
- Target cancer metabolism and signaling pathways
Why Repurposed Drugs Matter in Pancreatic Cancer
Pancreatic cancer remains one of the most difficult cancers to treat. Traditional therapies often provide limited survival benefit. Drug repurposing offers a promising alternative because:
- These drugs already have known safety profiles
- They are often low-cost and widely available
- They may target multiple cancer pathways simultaneously
According to a review of pancreatic cancer therapies, repurposed drugs represent a “very promising therapeutic option” with both preclinical and emerging clinical evidence .
Key Repurposed Drugs Being Studied
1. Metformin (Diabetes Drug)
Mechanism of Action
Metformin targets cancer metabolism by:
- Activating AMPK (energy sensor)
- Inhibiting mTOR signaling
- Reducing insulin/IGF-1 growth signaling
Evidence
- Studies show metformin may reduce pancreatic cancer risk and progression
- It has been evaluated in clinical trials for advanced pancreatic cancer
- Laboratory research shows metformin can inhibit metastasis and cancer stem cells
👉 Example research:
- https://pmc.ncbi.nlm.nih.gov/articles/PMC11595001/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6049054/
Bottom Line
Metformin is one of the most studied repurposed drugs in oncology, with both epidemiologic and clinical evidence suggesting benefit.
2. Ivermectin (Anti-Parasitic Drug)
Mechanism of Action
Ivermectin appears to:
- Inhibit cancer cell proliferation
- Disrupt mitochondrial function
- Block key signaling pathways (e.g., STAT3, mTOR)
Evidence
- A combination of ivermectin + gemcitabine showed greater tumor suppression than chemotherapy alone
- The combination increased apoptosis (cancer cell death) and reduced tumor growth in animal models
👉 Example research:
Bottom Line
Ivermectin shows strong preclinical synergy with chemotherapy, but human clinical evidence is still limited.
3. Mebendazole (Anti-Parasitic Drug)
Mechanism of Action
- Disrupts microtubules (like some chemotherapy drugs)
- Inhibits tumor growth and angiogenesis
Evidence
- Research from Johns Hopkins found mebendazole can collapse pancreatic cancer cell structure and reduce tumor growth
- Broad anti-cancer activity has been documented across tumor types
👉 Example research:
- https://www.hopkinsmedicine.org/news/newsroom/news-releases/2021/08/johns-hopkins-study-anti-parasitic-drug-slows-pancreatic-cancer-in-mice
- https://ecancer.org/en/journal/article/443-repurposing-drugs-in-oncology-redo-mebendazole-as-an-anti-cancer-agent
Bottom Line
Mebendazole is a low-toxicity candidate with encouraging laboratory results.
4. Fenbendazole (Veterinary Anti-Parasitic)
Mechanism of Action
- Disrupts microtubules
- May interfere with glucose metabolism in cancer cells
Evidence
- Early studies suggest anti-tumor effects in pancreatic cancer models, but research remains preliminary
👉 Example research:
Bottom Line
Promising but not yet supported by clinical trials in humans.
5. Disulfiram (Alcohol Dependence Drug)
Mechanism of Action
- Inhibits aldehyde dehydrogenase (ALDH)
- Targets cancer stem cells
- Enhances oxidative stress
Evidence
- When combined with metformin, disulfiram showed enhanced anti-tumor effects in preclinical models
👉 Example research:
Bottom Line
Disulfiram may be most effective in combination therapies, particularly targeting resistant cancer cells.
Advantages of Repurposed Drugs
- ✅ Lower cost vs. new oncology drugs
- ✅ Known dosing and safety
- ✅ Potential to combine with standard therapies
- ✅ Multi-targeted mechanisms
These drugs often show anti-proliferative, pro-apoptotic, and immune-modulating effects across multiple cancer types .
Limitations and Risks
- ⚠️ Most evidence is preclinical (lab or animal studies)
- ⚠️ Limited large-scale human trials
- ⚠️ Optimal dosing for cancer is often unknown
- ⚠️ Potential interactions with chemotherapy
Experts emphasize that promising lab results do not always translate into clinical benefit .
Integrative Oncology Perspective
Repurposed drugs may fit best into an integrative oncology approach, combined with:
- Standard treatments (chemotherapy, surgery)
- Nutrition (anti-inflammatory, metabolic support)
- Lifestyle therapies (exercise, sleep, stress reduction)
- Evidence-based supplements
Key Takeaways
- Repurposed drugs offer a promising, low-cost strategy for pancreatic cancer
- Metformin, ivermectin, and mebendazole have the strongest evidence so far
- Most research is still early-stage, requiring clinical validation
- Combination therapies may provide the greatest benefit
Evidence Appendix (PubMed / Primary Sources)
- https://pmc.ncbi.nlm.nih.gov/articles/PMC11595001/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC8394389/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC9459089/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6049054/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC10251882/
- https://ecancer.org/en/journal/article/443-repurposing-drugs-in-oncology-redo-mebendazole-as-an-anti-cancer-agent
- Repurposed Drugs for Pancreatic Cancer
- Repurposed Drugs for Pancreatic Cancer
- Repurposed Drugs for Pancreatic Cancer